Enteric formulations of physiologically active peptides and proteins
US5350741A · kind A · utility
207Cited by
8References
20Claims
0Family size
Inventor
Key dates
| Filing date | May 26, 1992 |
| Grant date | Sep 27, 1994 |
| Priority date | — |
| Expiry date | May 26, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/553
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An enteric formulation for a proteinous drug which protects it from enzymatic degradation and promotes its uptake by the intestinal tract when administered orally, comprises either a solid mass of an intimate mixture of the drug, a nontoxic nonionic surfactant, and an enteric material, or a solid mass of an intimate mixture of the drug with the nonionic surfactant covered by a discrete enteric coating.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.